Drugs / rVSV∆G-MARV-GP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07425821 | Mar 2026 → Nov 2027 expected | Marburg hemorrhagic fever | International AIDS Vaccine Initiative | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rVSV∆G-MARV-GP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07425821 ↗ |
| Modality | Vaccine | “rVSV Marburg virus vaccine” NCT07425821 ↗ |